首页> 外文期刊>Reproductive medicine and biology >Comparison between the gonadotropin-releasing hormone antagonist protocol and the gonadotropin-releasing hormone agonist long protocol for controlled ovarian hyperstimulation in the first in vitro fertilization-embryo transfer cycle in an unspecified population of infertile couples
【24h】

Comparison between the gonadotropin-releasing hormone antagonist protocol and the gonadotropin-releasing hormone agonist long protocol for controlled ovarian hyperstimulation in the first in vitro fertilization-embryo transfer cycle in an unspecified population of infertile couples

机译:未明确的不育夫妇在第一个体外受精-胚胎移植周期中控制性卵巢过度刺激的促性腺激素释放激素拮抗剂方案与促性腺激素释放激素激动剂长方案之间的比较

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose We aimed to compare the efficacy of a gonadotropin-releasing hormone (GnRH) antagonist protocol and a GnRH agonist long protocol used in the first in vitro fertilization-embryo transfer (IVF-ET) cycle in an unspecified population of infertile couples. Methods Fifty and 34 patients were treated with a GnRH agonist long protocol (agonist group) and GnRH antagonist protocol (antagonist group), respectively, in the first treatment cycle. The primary and secondary outcome measures were cumulative live birth rates after fresh and cryopre-served-thawed ETs and incidence of grades II and III ovarian hyperstimulation syndrome (OHSS), respectively. Results No significant differences were observed in clinical pregnancy rates (38.0 vs. 32.4%) and live birth rates (22.0 vs. 23.5%), which included both fresh and cryopreserved-thawed ETs, between the 2 groups. However, the incidence of grade III OHSS was significantly lower with the GnRH antagonist protocol than the GnRH agonist long protocol.Conclusions Used in the first IVF-ET cycle in an unspecified population of infertile patients, the GnRH antagonist protocol showed the same clinical outcome as the GnRH agonist long protocol.
机译:目的我们旨在比较促性腺激素释放激素(GnRH)拮抗剂方案和GnRH激动剂长方案在未明确说明的不育夫妇群体中的第一个体外受精-胚胎移植(IVF-ET)周期中的功效。方法在第一个治疗周期中分别对50例和34例患者进行了GnRH激动剂长方案(激动剂组)和GnRH拮抗剂方案(拮抗剂组)治疗。主要和次要结局指标分别是新鲜和冷冻保存的ET后的活产累积率,以及II级和III级卵巢过度刺激综合征(OHSS)的发生率。结果两组之间的临床妊娠率(38.0%vs. 32.4%)和活产率(22.0%vs. 23.5%)没有显着差异,其中包括新鲜和冷冻保存的ET。然而,GnRH拮抗剂方案的III级OHSS发生率显着低于GnRH激动剂长方案。结论在未明确的不育患者群体的第一个IVF-ET周期中使用的GnRH拮抗剂方案显示出与GnRH激动剂长期方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号